a month ago
MRNA
AnalystsMyles MinterMyles Minter's Stock Forecasts
AnalystsMyles Minter
Sectors:
Analyst Ranking
Top 26%
#1397 out of 5511 analysts
Average Return
+16.32%
Win Rate
60%12 out of 20
Risk vs Reward
Poor
Good
Myles Minter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | +413.28% | $18.38 | $94.34 | 2025-07-02 - 2026-07-02 | Buy |
Karuna Therapeutics IncKRTX | +58.10% | $208.62 | $329.83 | 2023-07-13 - 2024-03-15 | Buy |
Alnylam Pharmaceuticals IncALNY | +43.99% | $134.01 | $192.96 | 2022-06-07 - 2023-06-06 | Buy |
Neumora Therapeutics IncNMRA | +37.87% | $11.17 | $15.40 | 2023-10-10 - 2024-10-10 | Buy |
Argenx SeARGX | +37.43% | $595.58 | $818.50 | 2024-11-01 - 2025-10-31 | Buy |
Myles Minter Analyst Color
Get additional color on Myles Minter's coverage of popular stocks
Myles Minter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 2 | Buy | N/A | N/A | Upgrades | a month ago |
Korro Bio IncKRRO | 3 | Buy | N/A | N/A | Upgrades | 7 months ago |
Neumora Therapeutics IncNMRA | 2 | Buy | N/A | N/A | Upgrades | 7 months ago |
Biohaven LtdBHVN | 1 | Hold | N/A | N/A | Downgrades | 10 months ago |
Alector IncALEC | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Verve Therapeutics IncVERV | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Vigil Neuroscience IncVIGL | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Immunic IncIMUX | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Argenx SeARGX | 2 | Buy | N/A | N/A | Upgrades | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Buy | $71.00 | N/A | Initiates Coverage On | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Buy | N/A | N/A | Maintains | 3 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Praxis Precision Medicines IncPRAX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Larimar Therapeutics IncLRMR | 3 | Buy | N/A | N/A | Upgrades | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Buy | N/A | N/A | Upgrades | 5 years ago |
Translate Bio IncTBIO1 | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $116.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.